Development of Theophylline Effervescent Powder for Pulmonary Drug Delivery

Main Article Content

Theerawoot Seetawun
Pratchapon Tarnsuwan
Wutchara Junkheiw
Jintana Napaporn

Abstract

Introduction: The objective of this current study was to develop theophylline effervescent powder for pulmonary drug delivery. The spray-drying technique combined with effervescence technique was utilized as the means to improve water solubility and hygroscopic properties of theophylline. There were formulations developed in this study, i.e. Conventional Theophylline Powder, Effervescent Base Powder, Theophylline Effervescent Powder and Theophylline Effervescent Powder +PEG. The hygroscopic properties, polymorphism change, water solubility and content analysis of those formulations were assessed. Result: The spray-drying technique combined with effervescence technique proved to be able to produce dry powder for inhalers. However the characteristics of those spray-dried powders showed to be very hygroscopic. When incorporated PEG 1500 (5 and 10%) into formulations was effective to reduce its hygroscopicity. The preliminary solubility test had shown that Theophylline Effervescent Powder dissolved fastest in water and Theophylline Effervescent Powder+PEG dissolved slowest. The polymorphism of all formulations prepared by spray-drying technique was amorphous form. Content analysis of theophylline in those formulations was in the range of 95.40 – 104.51%. Conclusion: The spray-drying technique combined with effervescence technique proved to be able to produce dry powder for inhalers, which powder had amorphous form, improve dissolved water solubility of theophylline and PEG were incorporated that can be reduce its hygroscopicity. This results can develop for pulmonary drug delivery in the future.

Article Details

Section
Research Articles

References

Asada M, Takahashi H, Okamoto H, Tanino H, Danjo K. Theophylline particle design using chitosan by the spray drying. Int J Pharm. 2004 Feb 11; 270(1-2):167-74. PubMed PMID: 14726132

Britist Pharmacopoeia Commission Office. Britist Pharmacopoeia 2013 volume III. London: The stationery office; 2012. p.3450

Ely L, Roa W, Finlay WH, Löbenberg R. Effervescent dry powder for respiratory drug delivery. Eur J Pharm Biopharm. 2007 Mar; 65(3):346-53. PubMed PMID: 17156987

Kastrup EK, Editor. Drug Fact & Comparisons ® 2012 Edition. Las Vegus, Nevada: Wolters Kluwer Health;

Pritawin K, Chomchalaow A, Saneha A. Development of theophylline effervescent dry powder for pulmonary drug delivery [dissertation]. Ubon Ratchathani: Ubon Ratchathani University; 2008

Tithong P, Phunawan W, Sinsuwan S. Development of theophylline effervescent dry powder for pulmonary drug delivery phase II [dissertation]. Ubon Ratchathani: Ubon Ratchathani University; 2010.

The United states Pharmacopieal Convention. USP26/NF31. Baltimore: United Book Press; 2012. P.535